Dr. med. Ansgar Felbecker
Leitender Arzt Klinik für Neurologie
Leiter Memory Clinic (Klinik für Neurologie)
Leitende(r) Arzt/Ärztin
Neurologie · Dept. III
Effektivität der nichtinvasiven intermittierenden Maskenheimbeatmung bei Patienten mit amyotropher Lateralsklerose - Ergebnisse der Ulmer Heimbeatmungsdatenbank
Fink B, Felbecker A, Dorst J, Gdynia H, Sperfeld A, Ludolph A, Kühnlein P (2007). Effektivität der nichtinvasiven intermittierenden Maskenheimbeatmung bei Patienten mit amyotropher Lateralsklerose - Ergebnisse der Ulmer Heimbeatmungsdatenbank. Präsentiert bei: Jahrestagung der Deutschen Gesellschaft für Neurologie (DGN), Berlin
12.09.2007Effektivität der nichtinvasiven intermittierenden Maskenheimbeatmung bei Patienten mit amyotropher Lateralsklerose - Ergebnisse der Ulmer Heimbeatmungsdatenbank
12.09.2007Jahrestagung der Deutschen Gesellschaft für Neurologie (DGN)
Fink Bernhard, Felbecker Ansgar, Dorst Johannes, Gdynia Hans-Jürgen, Sperfeld Anne-Dörte, Ludolph Albert C., Kühnlein Peter
DRUG INTERACTION BETWEEN PHENPROCOUMON AND VALPROATE: CLINICALLY RELEVANT INCREASE OF INR IN PATIENTS WITH ISCHEMIC STROKE AND SYMPTOMATIC SEIZURES
Tettenborn B, Felbecker A, Weder B (2006). DRUG INTERACTION BETWEEN PHENPROCOUMON AND VALPROATE: CLINICALLY RELEVANT INCREASE OF INR IN PATIENTS WITH ISCHEMIC STROKE AND SYMPTOMATIC SEIZURES. Präsentiert bei: 7th European Congress on Epileptology: Helsinki, Finland, 2-6 July 2006: Platform Session, Helsinki, Finland
01.12.2006DRUG INTERACTION BETWEEN PHENPROCOUMON AND VALPROATE: CLINICALLY RELEVANT INCREASE OF INR IN PATIENTS WITH ISCHEMIC STROKE AND SYMPTOMATIC SEIZURES
01.12.20067th European Congress on Epileptology: Helsinki, Finland, 2-6 July 2006: Platform Session
Tettenborn Barbara, Felbecker Ansgar, Weder Bruno
CT-Perfusion-Imaging with Acetacolamide-Challenge: Leading the way to intervention
Felbecker A, Siebel P, Sarikaya H, Kluckert J, Tettenborn B. CT-Perfusion-Imaging with Acetacolamide-Challenge: Leading the way to intervention. International Journal of Stroke Vol. 1 2006; Supplement 1:55-55.
01.11.2006CT-Perfusion-Imaging with Acetacolamide-Challenge: Leading the way to intervention
01.11.2006International Journal of Stroke Vol. 1 2006; Supplement 1:55-55
Felbecker Ansgar, Siebel Philip, Sarikaya H, Kluckert Jörg-Thomas, Tettenborn Barbara
Involuntary movements during
Felbecker A, Erdelyi B, Hertle T, Bönig L, Weder B. Involuntary movements during. S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2006; 156(07):371-391
27.10.2006Involuntary movements during
27.10.2006S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2006; 156(07):371-391
Felbecker Ansgar, Erdelyi Barbara, Hertle Tobias, Bönig Lutz, Weder Bruno
CT PERFUSION IMAGING WITH ACETAZOLAMIDE CHALLENGE: LEADING THE WAY TO INTERVENTION
Siebel P, Felbecker A, Sarikaya H, Kluckert T, Tettenborn B (2006). CT PERFUSION IMAGING WITH ACETAZOLAMIDE CHALLENGE: LEADING THE WAY TO INTERVENTION. Präsentiert bei: Joint World Congress on Stroke, Cape Town, South Africa
26.10.2006CT PERFUSION IMAGING WITH ACETAZOLAMIDE CHALLENGE: LEADING THE WAY TO INTERVENTION
26.10.2006Joint World Congress on Stroke
Siebel Philip, Felbecker Ansgar, Sarikaya Hakan, Kluckert Thomas, Tettenborn Barbara
Spinal cord infarction after skiing – or fibrocartilaginous embolism (FCE)
Sarikaya H, Erdelyi B, Siebel P, Felbecker A, Tettenborn B (2006). Spinal cord infarction after skiing – or fibrocartilaginous embolism (FCE). Präsentiert bei: 177. Tagung der Schweizerischen Neurologischen Gesellschaft, Interlaken
19.10.2006Spinal cord infarction after skiing – or fibrocartilaginous embolism (FCE)
19.10.2006177. Tagung der Schweizerischen Neurologischen Gesellschaft
Sarikaya Hakan, Erdelyi Barbara, Siebel Philip, Felbecker Ansgar, Tettenborn Barbara
Spinal cord infarction after skiing – or fibrocartilaginous embolism (FCE)
Sarikaya H, Erdelyi B, Siebel P, Felbecker A, Tettenborn B. Spinal cord infarction after skiing – or fibrocartilaginous embolism (FCE). S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2006; 157(07):333-339
01.07.2006Spinal cord infarction after skiing – or fibrocartilaginous embolism (FCE)
01.07.2006S C H W E I Z E R A R C H I V F Ü R N E U R O L O G I E U N D P S Y C H I A T R I E 2006; 157(07):333-339
Sarikaya Hakan, Erdelyi Barbara, Siebel Philip, Felbecker Ansgar, Tettenborn Barbara
Clinical Relevance of Drug Interactions between Valproate and Oral Anticoagulants
Felbecker A, Weder B, Tettenborn B (2006). Clinical Relevance of Drug Interactions between Valproate and Oral Anticoagulants.
01.04.2006Clinical Relevance of Drug Interactions between Valproate and Oral Anticoagulants
01.04.2006American Academy of Neurology (AAN) congress,
Felbecker Ansgar, Weder Bruno, Tettenborn Barbara
Clinical Relevance of Drug Interactions between Valproate and Oral Anticoagulants
Felbecker A, Weder B, Tettenborn B (2006). Clinical Relevance of Drug Interactions between Valproate and Oral Anticoagulants. Präsentiert bei: American Academy of Neurology (AAN) congress, San Diego
04.03.2006Clinical Relevance of Drug Interactions between Valproate and Oral Anticoagulants
04.03.2006American Academy of Neurology (AAN) congress
Felbecker Ansgar, Weder Bruno, Tettenborn Barbara
Involuntary movements during yawning of an otherwise plegic arm in a patient with acute ischaemic stroke
Felbecker A, Erdelyi B, Hertle T, Bönig L, Weder B (2005). Involuntary movements during yawning of an otherwise plegic arm in a patient with acute ischaemic stroke. Präsentiert bei: 176. Tagung der Schweizerischen Neurologischen Gesellschaft, St. Gallen
27.10.2005Involuntary movements during yawning of an otherwise plegic arm in a patient with acute ischaemic stroke
27.10.2005176. Tagung der Schweizerischen Neurologischen Gesellschaft
Felbecker Ansgar, Erdelyi Barbara, Hertle Tobias, Bönig Lutz, Weder Bruno
Clinically Relevant Drug Interaction Between Valproate and the Oral Anticoagulant Phenprocoumon
Felbecker A, Tettenborn B, Weder B. Clinically Relevant Drug Interaction Between Valproate and the Oral Anticoagulant Phenprocoumon - Klinisch relevante Interaktion zwischen Valproat und Phenprocoumon. Aktuelle Neurologie 2005; 2005; 32:288-290.
04.06.2005Clinically Relevant Drug Interaction Between Valproate and the Oral Anticoagulant Phenprocoumon
04.06.2005Aktuelle Neurologie 2005; 2005; 32:288-290
Felbecker Ansgar, Tettenborn Barbara, Weder Bruno
Basilar artery occlusive disease – a case report with benign outcome
Siebel P, Felbecker A, von Hessling A, Tettenborn B. Basilar artery occlusive disease – a case report with benign outcome. Schweiz Arch Neurol Psych 2005 2005; 156:390-391, Abstract.
01.01.2005Basilar artery occlusive disease – a case report with benign outcome
01.01.2005Schweiz Arch Neurol Psych 2005 2005; 156:390-391, Abstract
Siebel Philip, Felbecker Ansgar, von Hessling A, Tettenborn Barbara
Clinical relevance of drug interaction between valproate and phenprocoumon
Felbecker A, Weder B, Tettenborn B. Clinical relevance of drug interaction between valproate and phenprocoumon. Epilepsia 2005; 46 (suppl. 6):267.
01.01.2005Clinical relevance of drug interaction between valproate and phenprocoumon
01.01.2005Epilepsia 2005; 46 (suppl. 6):267
Felbecker Ansgar, Weder Bruno, Tettenborn Barbara
Klinisch relevante Interaktion zwischen Valproat und Phenprocoumon
Felbecker A, Weder B, Tettenborn B. Klinisch relevante Interaktion zwischen Valproat und Phenprocoumon. Akt Neurol 2005; 32:288-290.
01.01.2005Klinisch relevante Interaktion zwischen Valproat und Phenprocoumon
01.01.2005Akt Neurol 2005; 32:288-290
Felbecker Ansgar, Weder Bruno, Tettenborn Barbara
Valporate and phenprocoumon: Is there an interaction of clinical relevance?
Felbecker A, Weder B, Tettenborn B. Valporate and phenprocoumon: Is there an interaction of clinical relevance?. Cardiovasc 2005; 6:13.
01.01.2005Valporate and phenprocoumon: Is there an interaction of clinical relevance?
01.01.2005Cardiovasc 2005; 6:13
Felbecker Ansgar, Weder Bruno, Tettenborn Barbara
Clinically relevant rise of International Normalized Ratio (INR) values in patients with ischemic stroke and symptomatic seizures: drug interaction between phenprocoumon and valproate
Felbecker A, Weder B, Tettenborn B. Clinically relevant rise of International Normalized Ratio (INR) values in patients with ischemic stroke and symptomatic seizures: drug interaction between phenprocoumon and valproate. Schweiz Arch Neurol Psych 2005; 156:379-379.
01.01.2005Clinically relevant rise of International Normalized Ratio (INR) values in patients with ischemic stroke and symptomatic seizures: drug interaction between phenprocoumon and valproate
01.01.2005Schweiz Arch Neurol Psych 2005; 156:379-379
Felbecker Ansgar, Weder Bruno, Tettenborn Barbara
Bilateral brachial plexus involvement on magnetic resonance imaging in a patient with clinically asymmetrical Lewis-Sumner syndrome
Felbecker A, Weber M, Tettenborn B (2004). Bilateral brachial plexus involvement on magnetic resonance imaging in a patient with clinically asymmetrical Lewis-Sumner syndrome. Präsentiert bei: 174. Tagung der Schweizerischen Neurologischen Gesellschaft, Geneve
04.11.2004Bilateral brachial plexus involvement on magnetic resonance imaging in a patient with clinically asymmetrical Lewis-Sumner syndrome
04.11.2004174. Tagung der Schweizerischen Neurologischen Gesellschaft
Felbecker Ansgar, Weber Markus, Tettenborn Barbara
Bilateral brachial plexus involvement on magnetic resonance imaging in a patient with clinically asymmetrical Lewis-Sumner syndrome
Felbecker A, Weber M, Tettenborn B. Bilateral brachial plexus involvement on magnetic resonance imaging in a patient with clinically asymmetrical Lewis-Sumner syndrome. Schweiz Arch Neurol Psych 2004; 155:91-92.
01.01.2004Bilateral brachial plexus involvement on magnetic resonance imaging in a patient with clinically asymmetrical Lewis-Sumner syndrome
01.01.2004Schweiz Arch Neurol Psych 2004; 155:91-92
Felbecker Ansgar, Weber Markus, Tettenborn Barbara
Neue 5´-Isoformen des Glutamattransporters EAAT2: RNA-Sequenzen und genomische Organisation
Felbecker A. Neue 5´-Isoformen des Glutamattransporters EAAT2: RNA-Sequenzen und genomische Organisation. Universität Ulm. Medizinische Fakultät 2003
04.12.2003Neue 5´-Isoformen des Glutamattransporters EAAT2: RNA-Sequenzen und genomische Organisation
04.12.2003Universität Ulm. Medizinische Fakultät 2003
Felbecker Ansgar